Ocular Myasthenia Gravis - How Effective Is Low Dose Prednisone Long Term?

Update item information
Identifier 20200310_nanos_posters_228
Title Ocular Myasthenia Gravis - How Effective Is Low Dose Prednisone Long Term?
Creator Rashmi Verma, Mark Kupersmith
Subject Myasthenia, Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid), Ocular Motility
Description Ocular myasthenia gravis (OMG) therapy should address three issues - restoration of normal binocular vision. prevention of deterioration to generalize MG (GMG), and avoiding significant adverse effects of treatment. Prior studies suggest that moderate dose followed by low dose daily prednisone can accomplish this for at least two year. Long term issues however, have not beenaddressed. We hypothesize that OMG patients who had been treated or required daily low dose prednisone (< 7.5 mg daily) would maintain control of OMG and continue with a low rate of conversion to GMG.
Relation is Part of NANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
Contributor Primary Rashmi Verma
Contributor Secondary Mark Kupersmith
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2020-03
Format application/pdf
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Language eng
ARK ark:/87278/s6062rdt
Setname ehsl_novel_nam
Date Created 2020-04-21
Date Modified 2020-05-26
ID 1542096
Reference URL https://collections.lib.utah.edu/ark:/87278/s6062rdt
Back to Search Results